Lv22
186 积分 2021-06-11 加入
A Comprehensive Review of Marketed KRAS Inhibitors and Degraders: Challenges and Opportunities
1小时前
待确认
Emerging landscape of KRAS inhibitors in cancer treatment
1小时前
已完结
Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity
1天前
已完结
Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial
3天前
已完结
Bristol-Myers Squibb swallows last of antibody pioneers
4天前
已完结
Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab
4天前
已完结
New insights into the regulation of T cells by gamma(c) family cytokines
9天前
已完结
Discovery of a Selective and Potent Inhibitor of Cyclin-Dependent Kinase 12/13 Employing a Noncovalent Mechanism
16天前
已完结
Unexpected hepatotoxicity in a phase I study of TAS266, a novel tetravalent agonistic Nanobody® targeting the DR5 receptor
23天前
已完结
2025 Highlights in new targets for migraine treatment
24天前
已完结
皖公网安备34019202002308
